The latest announcement is out from IQVIA Holdings ( ($IQV) ). On December 9, 2025, IQVIA Holdings Inc. amended its Fifth Amended and Restated ...

IQVIA Holdings has significantly outperformed the broader S&P 500 Index in recent months, and analysts remain strongly ...

With only 11% of organizations reporting comprehensively organized and accessible data for AI applications, data readiness ...

If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...

MHTC unveils winner of the FMTH Programme, an initiative to elevate Malaysia's position as the preferred medical tourism ...

IQVIA and AWS said the collaboration reflects the growing need for cloud-based tools that can support large-scale trial ...

IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic ...

Acquisitions are part of deal acceleration in Artificial Intelligence, Digital Clinical Research, and Observability Technologies. Marvell ...

Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...

A month has gone by since the last earnings report for IQVIA Holdings (IQV). Shares have added about 6.4% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading ...

Malaysia Healthcare Travel Council (MHTC) marked a major milestone in its medical tourism journey today with the announcement of the Winner of the Flagship Medical Tourism Hospital (FMTH) Programme, ...

IQVIA Market Access Launch Pad is a dynamic and comprehensive suite of tools designed to support pharmaceutical companies in their product launch readiness. It integrates policy structure updates, ...